Add another layer to your #Business literacy. We at Serebral360° would love to know if the Forbes – Entrepreneurs article was helpful, leave a comment, like and share. Let’s dive in and discuss the information and put it to use to grow your business. #BusinessStrategy #ContentMarketing #WebDevelopment #BrandStrategy
Info@serebral360.com 762.333.1807 www.serebral360.com
Grap a copy of our NEW Business Stratgety Books #FFSS VOL1 and #FFSS VOL2
As medical cannabis legalization spreads, more patients are turning to the plant for their complaints and illnesses. According to a new report from CB2 Insights, sufferers of mood-related conditions such as depression, anxiety, and post-traumatic stress disorder accounted for the largest group of patients seeking cannabis as a medicine (34.77%). The next largest group of respondents (33.05%) said they used it for pain relief for conditions like migraines, chronic pain, and back problems. According to the study, 15.33% sought cannabinoid therapy for sleep-related disorders.
Some of their use runs counter to existing laws. While more than half of US states (33 plus Washington, DC) have medical cannabis frameworks, only 24 states list any mood-related disorder as a qualifying condition and in all of those cases only PTSD is listed. Most states have approved chronic and intractable pain as a qualifying condition for cannabis usage. In seven states plus Washington D.C., doctors can suggest cannabis for any condition they deem applicable, so lists of ailments are not required for recommendation.
CB2 Insights research also examined marijuana experience levels of patients entering into their state’s cannabis program, checking on more than 1,600 patients over a six-week period across seven states. Across all states, the most common experience level among patients was “Daily Usage” with 46.75% of respondents, followed by “No Experience” 22.35% and “Little Experience” 15.23%. The study qualifies “little experience” as the patient not having used cannabis in at least three years or having used it less than five times overall, and never for therapeutic purposes. The results highlight the need for comprehensive education materials, not just for patients but for regulatory bodies, government agencies, and healthcare practitioners.
No matter their experience level, consumers are always cautioned to “start low and go slow” on strength and quantity of cannabis. Lex Corwin, chief executive of the organic marijuana producer Stone Road Farms said, “I would urge people to start with a light dose with CBD majority strains and see how it affects their mood. You can also intake more but not less!”
The study also reviewed incorrect and misleading information online regarding medical marijuana. The authors found that patients on their own were likely to find “misinformation as opposed to useful information.” They recommend seeking a qualified medical professional rather than relying on the web.
One resource for the canna-curious is the ebook ‘Cannabis Is Medicine’ which reviews over 10,000 medical studies.
To download a copy of the report “Lack of Experience Found Within Large Portion of Medical Cannabis Patients” go to : www.cb2insights.com/naivepatientreport.
March 11, 2019 at 03:47PM
Forbes – Entrepreneurs